Jin Matrix, Up 26.23% on Rising Theme of COVID-19 (Treatment/Vaccine Development, etc.)

On the 18th, the COVID-19 (treatment/vaccine development, etc.) theme rose by 3.11% compared to the previous day, showing strength, while JinMatrix, a related stock attracting attention, surged by 26.23% compared to the previous day. JinMatrix is known as a specialized company developing diagnostic kits through biotechnology research.

[Graph] Major stock price changes in the COVID-19 (treatment/vaccine development, etc.) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, JinMatrix ranked 3rd in the quant financial ranking (out of 25 stocks), surpassing the theme's average scores in growth, stability, and profitability. This can be interpreted as JinMatrix having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.